Gastroenterology Advisor

Live Vaccines May Be Safe in Patients With IBD on Advanced Therapy

Live vaccines administered to patients with IBD on advanced therapy did not increase short-term hospitalizations.
PR Newswire

Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda

Equity Insider News Commentary - Global spending on cancer medicines reached $252 billion in 2024 and is forecast to exceed ...

Join Anixa Biosciences’ Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine

Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...

RedChip Companies, Inc.: Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine

Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine approachesManagement to discuss CAR-T clinical progress, completed Phase 1 breast can ...
BioSpace

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

Remission and Endoscopic Response with RINVOQ for Advanced and Difficult-to-Treat Crohn's Disease ...
BIOENGINEER

MRI Radiomics Model Predicts Survival in Colorectal Cancer With Liver Metastases

A multicenter study shows that a hybrid model combining MRI radiomics, delta features, and clinical variables predicts ...